Coverage
-
November 28, 2011
A U.S. Food and Drug Administration chemist charged with making trades using private information about companies with pending drug applications agreed to pay $3.7 million on Monday to settle the U.S. Securities and Exchange Commission's civil case.
1 other articles on this case.
View all »